|
US4617307A
(en)
|
1984-06-20 |
1986-10-14 |
Ciba-Geigy Corporation |
Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
|
|
US4889861A
(en)
|
1982-12-21 |
1989-12-26 |
Ciba-Geigy Corp. |
Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5114946A
(en)
|
1987-06-12 |
1992-05-19 |
American Cyanamid Company |
Transdermal delivery of pharmaceuticals
|
|
US4818541A
(en)
|
1987-08-19 |
1989-04-04 |
Schering Corporation |
Transdermal delivery of enantiomers of phenylpropanolamine
|
|
ATE164852T1
(de)
|
1990-01-24 |
1998-04-15 |
Douglas I Buckley |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
|
US5155100A
(en)
|
1991-05-01 |
1992-10-13 |
Ciba-Geigy Corporation |
Phosphono/biaryl substituted dipeptide derivatives
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
IT1291776B1
(it)
|
1997-02-07 |
1999-01-21 |
Menarini Ricerche Spa |
Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
|
|
IT1304888B1
(it)
|
1998-08-05 |
2001-04-05 |
Menarini Ricerche Spa |
Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
IT1307809B1
(it)
*
|
1999-10-21 |
2001-11-19 |
Menarini Ricerche Spa |
Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
|
|
HUP0301335A3
(en)
|
2000-04-12 |
2006-02-28 |
Novartis Ag |
Combination of organic compounds
|
|
EP1297826A1
(en)
|
2001-09-27 |
2003-04-02 |
Menarini Ricerche S.p.A. |
Nasal pharmaceutical compositions containing a NK-2 antagonist
|
|
TW200303742A
(en)
|
2001-11-21 |
2003-09-16 |
Novartis Ag |
Organic compounds
|
|
WO2003104200A1
(en)
|
2002-06-07 |
2003-12-18 |
Glaxo Group Limited |
N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
|
|
DK1537114T3
(da)
|
2002-08-07 |
2006-11-13 |
Novartis Ag |
Organiske forbindelser som midler til behandling af aldosteronmedierede tilstande
|
|
CN100447142C
(zh)
|
2002-11-18 |
2008-12-31 |
诺瓦提斯公司 |
咪唑并[1,5a]吡啶衍生物及治疗醛固酮所介导疾病的方法
|
|
CA2525764C
(en)
|
2003-05-20 |
2012-07-17 |
Novartis Ag |
N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
|
|
CA2568164A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
JP5179174B2
(ja)
|
2004-05-28 |
2013-04-10 |
ノバルティス ファーマ アーゲー |
アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ［１，５−ａ］ピリジン誘導体
|
|
US7612088B2
(en)
|
2004-05-28 |
2009-11-03 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
WO2006005726A2
(en)
|
2004-07-09 |
2006-01-19 |
Speedel Experimenta Ag |
Heterocyclic compounds
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
EP2418202B1
(en)
|
2006-03-31 |
2014-01-29 |
Novartis AG |
(4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors
|
|
US20090156875A1
(en)
|
2006-04-04 |
2009-06-18 |
Takafumi Tomioka |
Methane separation method, methane separation apparatus, and methane utilization system
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
CA2660701A1
(en)
|
2006-08-25 |
2008-03-06 |
Novartis Ag |
Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
|
|
EA200900811A1
(ru)
|
2006-12-18 |
2009-12-30 |
Новартис Аг |
Имидазолы в качестве ингибиторов альдостеронсинтазы
|
|
KR20090090395A
(ko)
|
2006-12-18 |
2009-08-25 |
노파르티스 아게 |
4-이미다졸릴-1,2,3,4-테트라히드로퀴놀린 유도체 및 알도스테론/11-베타-히드록실라제 억제제로서의 그의 용도
|
|
EP2094669A2
(en)
|
2006-12-18 |
2009-09-02 |
Novartis AG |
1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
|
|
RU2009139811A
(ru)
|
2007-03-29 |
2011-05-10 |
Новартис АГ (CH) |
Гетероциклические спиросоединения
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
WO2009035543A1
(en)
|
2007-09-07 |
2009-03-19 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
AR066169A1
(es)
|
2007-09-28 |
2009-07-29 |
Novartis Ag |
Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
|
|
EP2297113A1
(en)
|
2008-04-29 |
2011-03-23 |
Theravance, Inc. |
Dual-acting antihypertensive agents
|
|
AR072297A1
(es)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
|
|
ES2627377T3
(es)
|
2008-10-23 |
2017-07-27 |
Steba Biotech S.A. |
Peptidomiméticos que contienen RGD y sus usos
|
|
NZ596302A
(en)
|
2009-05-15 |
2014-01-31 |
Novartis Ag |
Aryl pyridine as aldosterone synthase inhibitors
|
|
JP5466759B2
(ja)
|
2009-05-28 |
2014-04-09 |
ノバルティス アーゲー |
ネプリライシン阻害剤としての置換アミノ酪酸誘導体
|
|
SG176009A1
(en)
|
2009-05-28 |
2011-12-29 |
Novartis Ag |
Substituted aminopropionic derivatives as neprilysin inhibitors
|
|
JP5640091B2
(ja)
*
|
2009-10-01 |
2014-12-10 |
カディラ・ヘルスケア・リミテッド |
脂質異常症および関連疾患の治療のための化合物
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
JP5999702B2
(ja)
|
2009-11-23 |
2016-09-28 |
パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. |
メラノコルチン−１受容体特異的環状ペプチド
|
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
|
HUE028051T2
(hu)
|
2010-12-15 |
2016-11-28 |
Theravance Biopharma R&D Ip Llc |
Neprilizin inhibitorok
|
|
JP5959065B2
(ja)
|
2011-02-17 |
2016-08-02 |
セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー |
ネプリライシン阻害剤としての置換アミノ酪酸誘導体
|
|
CN103748070B
(zh)
|
2011-05-31 |
2015-06-24 |
施万生物制药研发Ip有限责任公司 |
脑啡肽酶抑制剂
|
|
JP5959074B2
(ja)
|
2011-05-31 |
2016-08-02 |
セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー |
ネプリライシン阻害剤
|
|
TWI560172B
(en)
|
2011-11-02 |
2016-12-01 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
|
SMT201700306T1
(it)
|
2012-06-08 |
2017-07-18 |
Theravance Biopharma R&D Ip Llc |
Inibitori di neprilisina
|
|
DE102012014480A1
(de)
|
2012-07-21 |
2014-01-23 |
Daimler Ag |
Aufbau eines Innendekors
|
|
MX366149B
(es)
|
2012-08-08 |
2019-06-28 |
Theravance Biopharma R&D Ip Llc |
Inhibidores de neprilisina.
|
|
US20150218212A1
(en)
|
2012-08-21 |
2015-08-06 |
Fluorinov Pharma Inc. |
Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitors
|
|
TR201808541T4
(tr)
|
2013-02-14 |
2018-07-23 |
Novartis Ag |
Nep (nötr endopeptidaz) inhibitörleri olarak ikame edilmiş bisfenil butanoik fosfonik asit türevleri.
|
|
DK2964616T3
(en)
|
2013-03-05 |
2017-08-28 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
|
CN105473141A
(zh)
|
2013-03-15 |
2016-04-06 |
实发生物医学公司 |
治疗和/或预防心血管疾病的抗pcsk9化合物和方法
|
|
CA2934898A1
(en)
|
2014-01-30 |
2015-08-06 |
Theravance Biopharma R&D Ip, Llc |
5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors
|
|
CA2934936A1
(en)
|
2014-01-30 |
2015-08-06 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
|
TW201823222A
(zh)
*
|
2016-12-23 |
2018-07-01 |
財團法人生物技術開發中心 |
化合物、醫藥組成物及其用途
|